These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8412196)

  • 1. Clinical experience with the micronucleus assay.
    Garewal HS; Ramsey L; Kaugars G; Boyle J
    J Cell Biochem Suppl; 1993; 17F():206-12. PubMed ID: 8412196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of chemopreventive agents for lung and upper aerodigestive tract cancers.
    Kelloff GJ; Boone CW; Steele VK; Perloff M; Crowell J; Doody LA
    J Cell Biochem Suppl; 1993; 17F():2-17. PubMed ID: 8412195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1995; 23():1-9. PubMed ID: 8747372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micronuclei: a potential intermediate marker for chemoprevention of aerodigestive tract cancer.
    Benner SE; Wargovich MJ; Lippman SM; Hong WK
    J Cell Biochem Suppl; 1993; 17F():250-4. PubMed ID: 8412201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral cancer prevention: the case for carotenoids and anti-oxidant nutrients.
    Garewal H; Meyskens F; Friedman S; Alberts D; Ramsey L
    Prev Med; 1993 Sep; 22(5):701-11. PubMed ID: 8234210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.
    Lieberman R
    Urology; 2001 Apr; 57(4 Suppl 1):224-9. PubMed ID: 11295633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micronuclei in exfoliated human cells as a tool for studies in cancer risk and cancer intervention.
    Stich HF; Rosin MP
    Cancer Lett; 1984 Apr; 22(3):241-53. PubMed ID: 6713365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the micronucleus test on exfoliated cells to identify anti-clastogenic action in humans: a biological marker for the efficacy of chemopreventive agents.
    Rosin MP
    Mutat Res; 1992 Jun; 267(2):265-76. PubMed ID: 1376429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surrogate endpoint biomarkers for cervical cancer chemopreventive trials.
    Ruffin MT; Ogaily MS; Johnston CM; Gregoire L; Lancaster WD; Brenner DE
    J Cell Biochem Suppl; 1995; 23():113-24. PubMed ID: 8747385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-carotene and vitamin E in oral cancer prevention.
    Garewal HS
    J Cell Biochem Suppl; 1993; 17F():262-9. PubMed ID: 8412203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA adducts, micronuclei and leukoplakias as intermediate endpoints in intervention trials.
    Stich HF; Dunn BP
    IARC Sci Publ; 1988; (89):137-45. PubMed ID: 3058594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micronucleus assay of buccal mucosa cells in smokers with the history of smoking less and more than 10 years.
    Naderi NJ; Farhadi S; Sarshar S
    Indian J Pathol Microbiol; 2012; 55(4):433-8. PubMed ID: 23455775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential inhibitors of tobacco carcinogenesis.
    Hoffmann D; Rivenson A; Chung FL; Wynder EL
    Ann N Y Acad Sci; 1993 May; 686():140-60. PubMed ID: 8512245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of oral cancer: the need for effective biological monitoring.
    Pillai MR; Ravi D; Nair MK
    Singapore Dent J; 1997 Aug; 22(1):6-12. PubMed ID: 10597170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention.
    Monteiro de Oliveira Novaes JA; William WN
    Future Oncol; 2016 Oct; 12(20):2379-86. PubMed ID: 27329013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells.
    Beliën JA; Copper MP; Braakhuis BJ; Snow GB; Baak JP
    Carcinogenesis; 1995 Oct; 16(10):2395-400. PubMed ID: 7586141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials.
    Benner SE; Hong WK; Lippman SM; Lee JS; Hittelman WM
    J Cell Biochem Suppl; 1992; 16G():33-8. PubMed ID: 1469903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate biomarkers of precancer and their application in chemoprevention.
    Kelloff GJ; Malone WF; Boone CW; Steele VE; Doody LA
    J Cell Biochem Suppl; 1992; 16G():15-21. PubMed ID: 1469895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.